{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:38:46Z","timestamp":1792834726145,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Myocarditis is an inflammatory myocardial disease with potentially severe outcomes. Programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) regulate immune tolerance, but the association between lifelong genetically proxied circulating PD-1\/PD-L1 levels and broadly defined myocarditis remains uncertain. We investigated these associations and explored related plasma lipid species. We conducted bidirectional 2-sample Mendelian randomization using proteomic genome-wide association data from the UK Biobank Pharma Proteomics Project and INTERVAL. FinnGen Release 10 was the primary broadly defined myocarditis outcome, and an independent myocarditis genome-wide association study (GCST90018882) provided outcome-level validation. Complementary estimators, heterogeneity and pleiotropy diagnostics, influence analyses, MR-RAPS, and supportive meta-analyses were performed. Associations with 179 plasma lipid species were examined in exploratory analyses. Higher genetically proxied circulating PD-L1 was inversely associated with broadly defined myocarditis in UKB-PPP (odds ratio [OR] 0.834, 95% confidence interval [CI] 0.698\u20130.995;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0441), and the independent INTERVAL analysis yielded a concordant inverse estimate (OR 0.619, 95% CI: 0.434\u20130.883;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0083); no clear association was observed for PD-1. The MR-RAPS estimate retained the inverse direction; estimates against the independent broadly defined myocarditis dataset were also inverse, and supportive meta-analyses across protein and outcome sources yielded inverse pooled estimates. Reverse MR did not support effects of broadly defined myocarditis liability on circulating PD-1 or PD-L1. Exploratory lipid analyses identified nominal associations requiring confirmation. Higher genetically proxied circulating PD-L1 may be associated with a lower risk of broadly defined myocarditis, supporting further investigation of PD-L1-related immune regulation. These findings do not directly estimate the effects of pharmacologic PD-1\/PD-L1 blockade. The lipid findings are hypothesis-generating.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050475","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:00:42Z","timestamp":1787968842000},"page":"e50475","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Genetically proxied circulating PD-1\/PD-L1 levels and broadly defined myocarditis"],"prefix":"10.1097","volume":"105","author":[{"given":"Fengyi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8691-3666","authenticated-orcid":false,"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261024","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jama.2023.3371","article-title":"Diagnosis and treatment of acute myocarditis: a review.","volume":"329","author":"Ammirati","year":"2023","journal-title":"JAMA"},{"key":"R2-20261024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R3-20261024","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral myocarditis-incidence, diagnosis and management.","volume":"34","author":"Olejniczak","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R4-20261024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.46747\/cfp.680117","article-title":"Myocarditis and pericarditis after COVID-19 messenger RNA vaccines.","volume":"68","author":"Goldman","year":"2022","journal-title":"Can Fam Physician"},{"key":"R5-20261024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pop.2023.07.006","article-title":"Myocarditis and pericarditis.","volume":"51","author":"Spotts","year":"2024","journal-title":"Prim Care"},{"key":"R6-20261024","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0140-6736(11)60648-X","article-title":"Myocarditis.","volume":"379","author":"Sagar","year":"2012","journal-title":"Lancet"},{"key":"R7-20261024","doi-asserted-by":"crossref","first-page":"1271959","DOI":"10.3389\/fcvm.2023.1271959","article-title":"Causal relationship between COVID-19 and myocarditis or pericarditis risk: a bidirectional Mendelian randomization study.","volume":"10","author":"Liu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R8-20261024","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer.","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"key":"R9-20261024","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.107.709360","article-title":"Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.","volume":"116","author":"Grabie","year":"2007","journal-title":"Circulation"},{"key":"R10-20261024","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis.","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"R11-20261024","doi-asserted-by":"crossref","first-page":"155932","DOI":"10.1016\/j.cyto.2022.155932","article-title":"PD-1 inhibitor induces myocarditis by reducing regulatory T cells, activating inflammatory responses, promoting myocardial apoptosis and autophagy.","volume":"157","author":"Liu","year":"2022","journal-title":"Cytokine"},{"key":"R12-20261024","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ejhf.2289","article-title":"Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta\u2010analysis.","volume":"23","author":"Rubio\u2010Infante","year":"2021","journal-title":"European J of Heart Fail"},{"key":"R13-20261024","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"R14-20261024","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade.","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"R15-20261024","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R16-20261024","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","article-title":"Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders.","volume":"24","author":"Yang","year":"2021","journal-title":"Nat Neurosci"},{"key":"R17-20261024","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation.","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"R18-20261024","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"R19-20261024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pharmthera.2013.05.011","article-title":"The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.","volume":"140","author":"Billman","year":"2013","journal-title":"Pharmacol Ther"},{"key":"R20-20261024","doi-asserted-by":"crossref","first-page":"202S","DOI":"10.1093\/ajcn\/71.1.202S","article-title":"Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids.","volume":"71","author":"Kang","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R21-20261024","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00018-020-03715-4","article-title":"Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases.","volume":"78","author":"Tabassum","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"R22-20261024","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease.","volume":"130","author":"Poss","year":"2020","journal-title":"J Clin Invest"},{"key":"R23-20261024","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank.","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"R24-20261024","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R25-20261024","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R26-20261024","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations.","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"R27-20261024","doi-asserted-by":"crossref","first-page":"1136169","DOI":"10.3389\/fimmu.2023.1136169","article-title":"Causal relationships between gut microbiota and programmed cell death protein 1\/programmed cell death-ligand 1: a bidirectional Mendelian randomization study.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Immunol"},{"key":"R28-20261024","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R29-20261024","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype-phenotype associations.","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"R30-20261024","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R31-20261024","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R32-20261024","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1214\/19-AOS1866","article-title":"Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score.","volume":"48","author":"Zhao","year":"2020","journal-title":"Ann Statist"},{"key":"R33-20261024","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s00432-021-03740-1","article-title":"Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer.","volume":"147","author":"Yang","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"R34-20261024","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s12094-023-03333-z","article-title":"Unraveling the genetic associations between PD-1\/PD-L1 and 13 circulating biomarkers linked to physiological and pathological processes.","volume":"26","author":"Li","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"R35-20261024","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1007\/s00262-023-03501-8","article-title":"Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1\/programmed cell death-ligand-1.","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R36-20261024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies.","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm (2020)"},{"key":"R37-20261024","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R38-20261024","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R39-20261024","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization.","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:00:38Z","timestamp":1792832438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050475"}},"subtitle":["A bidirectional Mendelian randomization study with exploratory lipidomic analyses"],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":39,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050475","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"2026-02-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}